These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 30920455)

  • 1. Pathogenesis and treatment of autoimmune rheumatic diseases.
    Liu E; Perl A
    Curr Opin Rheumatol; 2019 May; 31(3):307-315. PubMed ID: 30920455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.
    Kim K; Cho SK; Han TU; Kim JH; Kang SJ; Kang C; Bae SC
    Lupus; 2013 Nov; 22(13):1336-40. PubMed ID: 24014567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of IRF5, STAT4 and BLK with systemic lupus erythematosus and other rheumatic diseases.
    Tsuchiya N; Ito I; Kawasaki A
    Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(2):57-65. PubMed ID: 20453440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors.
    Suarez-Gestal M; Calaza M; Dieguez-Gonzalez R; Perez-Pampin E; Pablos JL; Navarro F; Narvaez J; Marenco JL; Herrero-Beaumont G; Fernandez-Gutierrez B; Lamas JR; de la Serna AR; Ortiz AM; Carreño L; Cañete JD; Caliz R; Blanco FJ; Balsa A; Gomez-Reino JJ; Gonzalez A
    Arthritis Rheum; 2009 Sep; 60(9):2558-64. PubMed ID: 19714582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferon in rheumatic diseases.
    Muskardin TLW; Niewold TB
    Nat Rev Rheumatol; 2018 Mar; 14(4):214-228. PubMed ID: 29559718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT4: genetics, mechanisms, and implications for autoimmunity.
    Korman BD; Kastner DL; Gregersen PK; Remmers EF
    Curr Allergy Asthma Rep; 2008 Sep; 8(5):398-403. PubMed ID: 18682104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-major histocompatibility complex rheumatoid arthritis susceptibility genes.
    Kunz M; Ibrahim SM
    Crit Rev Immunol; 2011; 31(2):99-114. PubMed ID: 21542789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Contribution of PTPN22 to Rheumatic Disease.
    Mustelin T; Bottini N; Stanford SM
    Arthritis Rheumatol; 2019 Apr; 71(4):486-495. PubMed ID: 30507064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from precision medicine in rheumatology.
    Wampler Muskardin TL; Paredes JL; Appenzeller S; Niewold TB
    Mult Scler; 2020 Apr; 26(5):533-539. PubMed ID: 31965913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Factors of Autoimmune Diseases 2017.
    Ceccarelli F; Agmon-Levin N; Perricone C
    J Immunol Res; 2017; 2017():2789242. PubMed ID: 29270439
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment.
    Murphy G; Lisnevskaia L; Isenberg D
    Lancet; 2013 Aug; 382(9894):809-18. PubMed ID: 23972423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-regulatory mechanisms in systemic autoimmune and rheumatic diseases.
    Takakubo Y; Konttinen YT
    Clin Dev Immunol; 2012; 2012():941346. PubMed ID: 22110541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes in Children Born to Women with Rheumatic Diseases.
    Vinet É; Bernatsky S
    Rheum Dis Clin North Am; 2017 May; 43(2):263-273. PubMed ID: 28390568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic pathways mediate pathogenesis and offer targets for treatment in rheumatic diseases.
    Wyman B; Perl A
    Curr Opin Rheumatol; 2020 Mar; 32(2):184-191. PubMed ID: 31895126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypergammaglobulinemic purpura in systemic autoimmune rheumatic diseases: predictive value of anti-Ro(SSA) and anti-La(SSB) antibodies and treatment with indomethacin and hydroxychloroquine.
    Senécal JL; Chartier S; Rothfield N
    J Rheumatol; 1995 May; 22(5):868-75. PubMed ID: 8587074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis.
    Lee YH; Rho YH; Choi SJ; Ji JD; Song GG; Nath SK; Harley JB
    Rheumatology (Oxford); 2007 Jan; 46(1):49-56. PubMed ID: 16760194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetic contribution to systemic lupus erythematosus.
    Criswell LA
    Bull NYU Hosp Jt Dis; 2008; 66(3):176-83. PubMed ID: 18937628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current perspective on rituximab in rheumatic diseases.
    Schioppo T; Ingegnoli F
    Drug Des Devel Ther; 2017; 11():2891-2904. PubMed ID: 29042750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci.
    ; Harley JB; Alarcón-Riquelme ME; Criswell LA; Jacob CO; Kimberly RP; Moser KL; Tsao BP; Vyse TJ; Langefeld CD; Nath SK; Guthridge JM; Cobb BL; Mirel DB; Marion MC; Williams AH; Divers J; Wang W; Frank SG; Namjou B; Gabriel SB; Lee AT; Gregersen PK; Behrens TW; Taylor KE; Fernando M; Zidovetzki R; Gaffney PM; Edberg JC; Rioux JD; Ojwang JO; James JA; Merrill JT; Gilkeson GS; Seldin MF; Yin H; Baechler EC; Li QZ; Wakeland EK; Bruner GR; Kaufman KM; Kelly JA
    Nat Genet; 2008 Feb; 40(2):204-10. PubMed ID: 18204446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on epigenetic-based immune intervention for rheumatic diseases.
    Gray SG
    Arthritis Res Ther; 2013 Mar; 15(2):207. PubMed ID: 23510070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.